This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

July 27 - 29, 2021

Frederick Schnell, MD, FACP
Chief Medical Officer at Community Oncology Alliance


Frederick M. Schnell, MD, FACP brings the physician perspective and practice management experience to his role as Medical Director. Dr. Schnell is helping community oncology practices address the future of oncology payment reform. The rapidly changing landscape of cancer care delivery in the United States demands insight like his to craft the future strategies for community oncology.

Board certified in internal medicine and medical oncology, Dr. Schnell practiced for 34 years at Central Georgia Cancer Care where he served as CEO. His primary focus areas related to breast and genitourinary cancer.

Dr. Schnell is a past president of both COA and the Georgia Society of Clinical Oncology. He is currently the Medical Director of the Georgia Center for Research and Oncology Education, a prior member of the Board of Directors of the Patient Access Network Foundation and served for eight years as a member if the Board of Directors and the Chief Clinical Officer, Cancer Clinics of Excellence. He was named the Distinguished Cancer Clinician Award from the Georgia Cancer Coalition.

Dr. Schnell received his medical degree from Case Western Reserve University. He completed his internship and residency at Emory University Affiliated Hospitals, followed by a fellowship in medical oncology and hematology, also at Emory University. Additionally, he served in the National Health Services Corps, United States Public Health Service. 

His academic appointments include Clinical Assistant Professor, Department of Medicine, Mercer University School of Medicine, Macon, GA, and Clinical Assistant Professor of Hematology and Oncology at the Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA.

Agenda Sessions

  • OCM 2.0 — Analyze the New Reform Model to Lower Costs